Latest Period
Q1 2026
Security Snapshot
Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) Institutional Ownership
CUSIP: 03836J201
13F Institutional Holders and Ownership History from Q1 2023 to Q1 2026
Institutions Reporting
22
Shares (Excl. Options)
2,244,310
Price
$0.76
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, par value $0.001 per share
- Symbol
- APRE on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 2,244,310
- Total 13F value
- $1,712,195
- Portfolio coverage rank
- 0%
- Share change
- +536,313
- Value change
- +$356,352
- Number of holders
- 22
- Shares outstanding
- 9,144,889
- SEC-reported price per share
- $0.95
- Insider filing price
- $0.95
Latest holder snapshot
5 signals
Issuer context
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- APRE - Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share is tracked under CUSIP 03836J201.
- 22 institutions reported positions in Q1 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 22 to 22 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $1,446,275 to $1,712,195.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 22 institutions filings for Q1 2026.
Security key
03836J201
Latest holder period
Q1 2026
13F holders
22
13D/G owners
4
CIK / CUSIP context first
Open Q1 2026 holders
APRE full holder history
Aprea Therapeutics, Inc. SEC filings
Aprea Therapeutics, Inc. company facts
Aprea Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03836J201:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
APRE
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| LYTTON LAURENCE W | 9.9% | $913,662 | 681,837 | LYTTON LAURENCE W | 13 Nov 2025 | |||
| Nantahala Capital Management, LLC | 4.5% | -40% | $386,829 | 411,520 | 0% | Nantahala Capital Management, LLC | 31 Dec 2025 | |
| Stonepine Capital Management, LLC | 4.3% | -16% | $418,978 | -$82,213 | 239,416 | -16% | Stonepine Capital Management, LLC | 31 Mar 2025 |
| Sio Capital Management, LLC | 1.9% | -62% | $165,529 | -$246,540 | 112,223 | -60% | Sio Capital Management, LLC | 30 Sep 2025 |
As of 31 Mar 2026, 22 institutional investors reported holding 2,244,310 shares of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE). This represents 25% of the company’s total 9,144,889 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
25%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 11% | 1,015,541 | +174% | 0.16% | $774,757 |
| Vestal Point Capital, LP | 3.8% | 350,000 | 0.01% | $267,015 | |
| SPHERA FUNDS MANAGEMENT LTD. | 3% | 270,000 | 0% | 0.04% | $205,983 |
| Nantahala Capital Management, LLC | 2.2% | 205,760 | 0% | 0.01% | $156,974 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3% | 119,131 | +191% | 0% | $90,890 |
| Scientech Research LLC | 0.66% | 60,281 | 0.04% | $45,988 | |
| BNP PARIBAS FINANCIAL MARKETS | 0.44% | 39,817 | 0% | 0% | $30,376 |
| VANGUARD FIDUCIARY TRUST CO | 0.42% | 38,464 | 0% | 0% | $29,348 |
| RENAISSANCE TECHNOLOGIES LLC | 0.27% | 25,100 | 0% | $19,149 | |
| MORGAN STANLEY | 0.24% | 22,330 | -71% | 0% | $17,036 |
| LPL Financial LLC | 0.23% | 21,052 | -19% | 0% | $16,061 |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.21% | 19,622 | 0% | 0% | $14,972 |
| HighTower Advisors, LLC | 0.15% | 13,864 | 0% | 0% | $10,577 |
| TWO SIGMA SECURITIES, LLC | 0.15% | 13,500 | 0% | $10,299 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.14% | 13,018 | 0% | $9,931 | |
| BlackRock, Inc. | 0.09% | 8,504 | 0% | 0% | $6,487 |
| Tower Research Capital LLC (TRC) | 0.06% | 5,127 | -34% | 0% | $3,911 |
| UBS Group AG | 0.02% | 2,153 | -13% | 0% | $1,643 |
| GROUP ONE TRADING LLC | 0.01% | 577 | 0% | 0% | $440 |
| OSAIC HOLDINGS, INC. | 0% | 295 | -1.7% | 0% | $225 |
| WealthCollab, LLC | 0% | 158 | 0% | 0% | $121 |
| SBI Securities Co., Ltd. | 0% | 16 | +6.7% | 0% | $12 |
| Murchinson Ltd. | 0% | 0 | -100% | $0 | |
| CITADEL ADVISORS LLC | 0% | 0 | -100% | $0 | |
| XTX Topco Ltd | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
13
Latest
Q1 2026
Rows shown
1-13 of 13
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 2,244,310 | $1,712,195 | +$356,352 | $0.76 | 22 |
| 2025 Q4 | 1,695,512 | $1,446,275 | -$113,007 | $0.85 | 22 |
| 2025 Q3 | 1,618,851 | $2,387,744 | -$296,033 | $1.48 | 23 |
| 2025 Q2 | 1,815,508 | $3,072,270 | -$77,601 | $1.69 | 23 |
| 2025 Q1 | 1,847,462 | $3,768,839 | -$165,845 | $2.04 | 25 |
| 2024 Q4 | 2,077,381 | $6,829,282 | +$211,103 | $3.29 | 26 |
| 2024 Q3 | 2,000,189 | $5,500,414 | -$431,314 | $2.75 | 21 |
| 2024 Q2 | 2,083,045 | $8,477,419 | +$1,866,030 | $4.07 | 27 |
| 2024 Q1 | 1,624,394 | $10,764,195 | +$4,966,764 | $6.69 | 22 |
| 2023 Q4 | 926,780 | $4,355,977 | +$26,645 | $4.70 | 19 |
| 2023 Q3 | 876,935 | $3,660,270 | -$19,509 | $4.17 | 19 |
| 2023 Q2 | 881,553 | $2,776,892 | +$105,033 | $3.15 | 17 |
| 2023 Q1 | 848,237 | $3,769,266 | +$3,769,266 | $4.44 | 15 |